FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to veterinary science and concerns an adjuvant composition containing poly-gamma-glutamic acid. Substance of the invention includes said immunostimulant (adjuvant) composition containing poly-gamma-glutamic acid with molecular weight 1000 to 2000 kDa, an immunogen composition containing said immunostimulant composition and an antigen substance, and also a method for increasing rate of antigen antibody production that involves introduction of the immunogen composition the animals.
EFFECT: adjuvant is not toxic, has no by-effects and stimulates formation of high-titre antibodies even if applied with at its application with an immunogenic inferior antigen.
8 cl, 5 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ADJUVANT COMPOSITION, CONTAINING NANOPARTICLES OF POLY-GAMMA-GLUTAMIC ACID-CHITOSAN | 2010 |
|
RU2558794C2 |
| VECTOR ENABLING SARS VIRUS ANTIGEN EXPRESSION AT CELL SURFACE, AND MICROBES TRANSFORMED BY THIS VECTOR | 2004 |
|
RU2332457C2 |
| IMMUNOGENIC COMPOSITION | 2005 |
|
RU2405568C2 |
| STABLE VECTOR OF CONSTITUTIVELY HIGH EXPRESSION FOR OBTAINING HPV VACCINE, AND RECOMBINANT LACTIC ACID BACTERIA TRANSFORMED BY THIS VECTOR | 2010 |
|
RU2492240C2 |
| FMDV VACCINES BASED ON A RECOMBINANT ADENOVIRAL VECTOR AND USE THEREOF | 2017 |
|
RU2725495C2 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
| IMMUNOGENIC SUBSTANCES CONTAINING ADJUVANT OF POLYINOSINE ACID AND POLYCYTIDYLIC ACID | 2006 |
|
RU2462264C2 |
| VACCINES CONTAINING GENETIC VARIANTS OF CANINE PARVOVIRUS | 2008 |
|
RU2519210C2 |
| PRIME-BOOST MODES INVOLVING INTRODUCTION OF AT LEAST ONE MRNA STRUCTURE | 2016 |
|
RU2742993C2 |
